BGLC
BioNexus Gene Lab Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · MY
$1.57
+6.44%Jul 28, 2026, 13:00 UTC
BioNexus Gene Lab Corp. announced progress toward commercializing the VitaGuard MRD platform in Southeast Asia after a working visit to Tongshu Gene facilities in China.
Source: